Stock search

Ticker or company name

Compare stocks

Market: US

  • CVSCVS Health

Add stock

Ticker or company

Summary

CVS
CVS Health
$88,59Down −0,85%
Year: Up +13%
83/100Ratio would consider buying
Open stock page

Traffic light — 10 checks

CheckCVS6 ✓ 3 — 0 ✕
P/E vs its history10,4
P/E vs industry10,4
Forward P/E10,7
Revenue growth, YoY+6,7%
EPS growth, YoY+2 107,7%
Net margin2,6%
Net debt / EBITDA−0,8
Free cash flow$15,6 bn
Share count over a year+1,7%
Cash runwayn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterCVSTTMIndustry medianTTM
P/E TTM ↓10,425,1
Forward P/E ↓10,716,2
PEG ↓1,82,2
P/S TTM ↓0,32,2
EV/EBITDA ↓10,817,3
P/FCF ↓7,319,5

Price, %

  • CVSn/a

Returns

Best WorstNo mark — in between

PeriodCVS
1 yearn/a
3 yearsn/a
5 yearsn/a
All timen/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

CVS
Share of “buy”88%
Beat the forecast4 of 4
Average “surprise”+22,0%
Insiders over 12 monthssales $322 m

Details are on each stock page.